MedPath

PENTOXIFYLLINE

PENTOXIFYLLINE EXTENDED-RELEASE TABLETS, USP 400 mg

Approved
Approval ID

e09702d1-43d4-47ed-9563-5af3cd667727

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 23, 2014

Manufacturers
FDA

Aidarex Pharmaceuticals LLC

DUNS: 801503249

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PENTOXIFYLLINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code33261-992
Application NumberANDA075191
Product Classification
M
Marketing Category
C73584
G
Generic Name
PENTOXIFYLLINE
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 23, 2014
FDA Product Classification

INGREDIENTS (7)

PENTOXIFYLLINEActive
Quantity: 400 mg in 1 1
Code: SD6QCT3TSU
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYDROXYPROPYL CELLULOSE (TYPE H)Inactive
Code: RFW2ET671P
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3B
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PENTOXIFYLLINE - FDA Drug Approval Details